Suppr超能文献

肺淋巴管癌病所致呼吸衰竭

Respiratory failure due to pulmonary lymphangitis carcinomatosis.

作者信息

Fujita J, Yamagishi Y, Kubo A, Takigawa K, Yamaji Y, Takahara J

机构信息

First Department of Internal Medicine, Kagawa Medical School, Japan.

出版信息

Chest. 1993 Mar;103(3):967-8. doi: 10.1378/chest.103.3.967.

Abstract

A man with primary lung cancer developed respiratory failure due to lymphangitis carcinomatosis that was diagnosed by transbronchial lung biopsy specimen. After combination chemotherapy with high-dose etoposide and cisplatin (CDDP), he was able to cease oxygen therapy and showed improvement of his lymphangitis carcinomatosis. He received a total dose of 13,400 mg/m2 of etoposide. This case suggested that respiratory failure due to lymphangitis carcinomatosis can be a treatable condition.

摘要

一名原发性肺癌患者因癌性淋巴管炎出现呼吸衰竭,经支气管肺活检标本确诊。在接受高剂量依托泊苷和顺铂(CDDP)联合化疗后,他能够停止吸氧治疗,且癌性淋巴管炎有所改善。他接受的依托泊苷总剂量为13400mg/m²。该病例表明,癌性淋巴管炎所致呼吸衰竭是一种可治疗的病症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验